These findings extend our knowledge of tumor suppressive functions of BRCA1, providing a new perspective on metabolism regulation and raising the possibility that synthetically targeting aspartate metabolism may be a promising strategy for treatment of BRCA1‐deficient breast tumors. Here, BRCA1 is linked to neoplasm.